Rivastigmine for the Prevention of Postoperative Delirium in Patients Undergoing Cardiac Surgery

Phase 3 Completed 120 enrolled University Hospital, Basel, Switzerland Novartis · collab

RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to determine whether Rivastigmine is effective for the prevention of postoperative delirium in patients undergoing cardiac surgery.

Timeline

Start: 2006-01
Primary completion: —
Completion: 2007-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Rivastigmine	Small molecule	1.5 mg	Oral

Rivastigmine for the Prevention of Postoperative Delirium in Patients Undergoing Cardiac Surgery

Summary

Timeline

Drugs

Indications